CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And Characterization

CD8+ T Lymphocyte Epitopes From The Herpes Simplex Virus Type 2 ICP27, VP22 and VP13/14 Proteins To Facilitate Vaccine Design And Characterization

CD8+ T cells have the potential to control HSV-2 infection. However, limited information has been available on CD8+ T cell epitopes or the functionality of antigen specific T cells during infection or following immunization with experimental vaccines. Peptide panels from HSV-2 proteins ICP27, VP22 a...

Full description

Bibliographic Details
Main Authors: Rebecca J. Platt, Tansi Khodai, Tim J. Townend, Helen H. Bright, Paul Cockle, Luis Perez-Tosar, Rob Webster, Brian Champion, Timothy P. Hickling, Fareed Mirza
Format: Article
Language:English
Published: MDPI AG 2013-01-01
Series:Cells
Subjects:
HSV-2
CD8+ epitope
vaccine
infection
Online Access:http://www.mdpi.com/2073-4409/2/1/19

Internet

http://www.mdpi.com/2073-4409/2/1/19

Similar Items